Manufacturing capacity, complexity and cost are core constraints that limit commercialization of cell and gene therapies (CGT) and ultimately patient access. This event is being presented by leading thought leaders in cell and gene therapy innovation.
Germfree is leading a city-by-city educational series on core solutions and considerations for solving the inherent challenges in CGT manufacturing. New innovations in distributed and centralized manufacturing will be presented along with other core topics on how to make commercialization of these therapies a success.
This event is being presented by leading thought leaders in cell and gene therapy innovation, and tours of the mobile cleanroom will be provided.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
